Glyxambi 10/5 Mg & 25/5 Mg 5 mg, 10 mg, 25 mg Tablet
PDF Leaflet Revision Date: 01 November 2025
Clinical Summary
Quick overview from the medicine insert
Indication
Adjunct to diet and exercise for glycaemic control in adults with type 2 diabetes mellitus.
Dosage (summary)
Starting dose: GLYXAMBI 10/5 mg once daily; may increase to 25/5 mg if needed.
Special Populations
- Renal impairment
- Hepatic impairment
- Elderly patients
Pregnancy & Breastfeeding
Avoid use during pregnancy; not recommended during breastfeeding.
Key Drug Interactions
- Insulin and sulphonylureas may increase hypoglycaemia risk.
- Diuretics may increase dehydration risk.
- Lithium levels may decrease.
Contraindications
- Hypersensitivity to components
- Severe renal impairment (eGFR <30 mL/min/1.73 mu00b2)
- Type 1 diabetes
- Diabetic ketoacidosis
Common side effects
- Urinary tract infection
- Increased urination
- Hypoglycaemia
- Ketoacidosis
- Pancreatitis
Counselling Points
- Take once daily with or without food.
- Monitor for signs of ketoacidosis.
- Report any genital infections or severe joint pain.
Serious warnings
- Risk of diabetic ketoacidosis.
- Monitor for urinary tract infections.
- Caution in patients with volume depletion.
Important Disclaimer
The Glyxambi 10/5 Mg & 25/5 Mg 5 mg, 10 mg, 25 mg Tablet professional information leaflet below is the property of Ingelheim Pharmaceuticals and is provided on Medinsert exactly as issued, with no.. alterations or editorial changes. We make every effort to keep content current by updating documents as soon as new versions become available. Medinsert serves as a trusted access point for healthcare professionals, but does not replace official sources or clinical judgement. For more details, please read our full disclaimer. read more>>
Healthcare Professionals Only
This content is for registered healthcare professionals
Sign in or create a free account to read the full package insert.
Free for HPCSA-registered professionals. Powered by Medinsert.
